As of April 28, 2026, Achieve Life Sciences's top three insider holders are Thomas Braxton King (Director, 315.14K shares), Richard Alistair Stewart (Chief Executive Officer, 228.88K shares), Richard Alistair Stewart (Chief Executive Officer, 228.88K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Thomas Braxton King | - | 315,142 | 0 | 08 Sep, 2025 |
| Richard Alistair Stewart | Chief Executive Officer | 228,875 | 0 | 22 Sep, 2025 |
| Richard Alistair Stewart | Chief Executive Officer | 228,875 | 0 | 22 Sep, 2025 |
| Mark K Oki | Chief Financial Officer | 127,940 | 0 | 22 Sep, 2025 |
| Mark K Oki | Chief Financial Officer | 127,940 | 0 | 22 Sep, 2025 |
| Cindy Jacobs | President Cmo | 115,585 | 0 | 08 Sep, 2025 |
| John Bencich | Ceo | 100,636 | 0 | 20 Aug, 2024 |
| Jaime Xinos | Chief Commercial Officer | 74,432 | 0 | 08 Sep, 2025 |
| Jaime Xinos | Chief Commercial Officer | 74,432 | 0 | 08 Sep, 2025 |
| Jerry Wan | Principal Accounting Officer | 32,694 | 0 | 08 Sep, 2025 |
| Jerry Wan | Principal Accounting Officer | 32,694 | 0 | 08 Sep, 2025 |
| Anthony Clarke | Cso | 3,502 | 0 | 29 Apr, 2022 |
| Anthony Clarke | Cso | 3,502 | 0 | 29 Apr, 2022 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 18 Apr, 2026 | Andrew D. Goldberg | Restricted Stock Unit (RSU) | A | 1,800,965 | $0.00 | 1,800,965 | D | A |
| 18 Apr, 2026 | Andrew D. Goldberg | Stock Option (right to buy) | A | 3,601,929 | $0.00 | 3,601,929 | D | A |
| 18 Apr, 2026 | Andrew D. Goldberg | Performance Restricted Stock Unit (PRSU) | A | 11,706,270 | $0.00 | 11,706,270 | D | A |
| 04 Dec, 2025 | Erik Atkisson | Stock Option (right to buy) | A | 250,000 | $0.00 | 250,000 | D | A |
| 04 Dec, 2025 | Erik Atkisson | Stock Option (right to buy) | A | 250,000 | $0.00 | 250,000 | D | A |
| 01 Oct, 2025 | Craig Donnelly | Stock Option (right to buy) | A | 50,000 | $0.00 | 50,000 | D | A |
| 01 Oct, 2025 | Craig Donnelly | Stock Option (right to buy) | A | 50,000 | $0.00 | 50,000 | D | A |
| 18 Sep, 2025 | Mark K Oki | Common Stock | A | 168,000 | $0.00 | 178,000 | D | M |
| 18 Sep, 2025 | Richard Alistair Stewart | Common Stock | A | 297,500 | $0.00 | 358,376 | D | M |
| 18 Sep, 2025 | Richard Alistair Stewart | Common Stock | A | 297,500 | $0.00 | 358,376 | D | M |
| 18 Sep, 2025 | Mark K Oki | Common Stock | A | 168,000 | $0.00 | 178,000 | D | M |
| 18 Sep, 2025 | Mark K Oki | Common Stock | D | 50,060 | $2.92 | 127,940 | D | S |
| 18 Sep, 2025 | Richard Alistair Stewart | Common Stock | D | 129,501 | $2.92 | 228,875 | D | S |
| 18 Sep, 2025 | Richard Alistair Stewart | Common Stock | D | 129,501 | $2.92 | 228,875 | D | S |
| 18 Sep, 2025 | Mark K Oki | Common Stock | D | 50,060 | $2.92 | 127,940 | D | S |
| 18 Sep, 2025 | Mark K Oki | Performance Restricted Stock Unit (PRSU) | D | 168,000 | $0.00 | 0 | D | M |
| 18 Sep, 2025 | Mark K Oki | Performance Restricted Stock Unit (PRSU) | D | 168,000 | $0.00 | 0 | D | M |
| 18 Sep, 2025 | Richard Alistair Stewart | Performance Restricted Stock Unit (PRSU) | D | 140,000 | $0.00 | 0 | D | M |
| 18 Sep, 2025 | Richard Alistair Stewart | Performance Restricted Stock Unit (PRSU) | D | 140,000 | $0.00 | 0 | D | M |
| 18 Sep, 2025 | Richard Alistair Stewart | Performance Restricted Stock Unit (PRSU) | D | 157,500 | $0.00 | 0 | D | M |